Tag Archives: misrepresentation of FDA clearance as FDA approval needs non-anecdotal evidence of consumer deception to be actionable false advertising

misrepresentation of FDA clearance as FDA approval needs non-anecdotal evidence of consumer deception to be actionable

Repro-Med Sys., Inc. v. EMED Technol. Corp., 2019 WL 1427978, No. 13-cv-01957-TLN-CKD (E.D. Cal. Mar. 29, 2019) The parties have been fighting over their competing medical devices for a while. Here, RMS alleged among other things that EMED was intentionally … Continue reading

Posted in Uncategorized | Tagged | Leave a comment